Rapport Therapeutics Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Rapport Therapeutics Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Boston
- Headquarters state / province
- Massachusetts
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- RAPP
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0002012593
- EIN
- 88-0724208
Board of directors
-
Abraham Ceesay · Director · Chief Executive OfficerSince 2024
- Since 2024
-
Jeffrey K. Tong · DirectorSince 2024
- Since 2024
-
Paul M. Silva · DirectorSince 2024
-
Ramiro Sanchez · DirectorSince 2024
-
Reid M. Huber · DirectorSince 2024
-
Robert J. Perez · DirectorSince 2024
-
Steven M. Paul · DirectorSince 2024
-
Terry-Ann Burrell · DirectorSince 2024
-
Wendy B. Young · DirectorSince 2024
Chief executives
Abraham Ceesay
· Chief Executive Officer
Dates unknown
Director election results
Annual meeting of June 10, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
88.8%
-
98.6%
-
98.6%
Board connections
11 of this board's directors also sit on 22 other boards.
- via James Healy and Steven M. Paul
- via Wendy B. Young
- via John Maraganore
- via Ramiro Sanchez
- via James Healy
- via John Maraganore
- via James Healy
- via James Healy
- via Abraham Ceesay
- via John Maraganore
- via Robert J. Perez
- via John Maraganore
- via Jeffrey K. Tong
- via James Healy
- via Paul M. Silva
- via Abraham Ceesay
- via John Maraganore
- via Terry-Ann Burrell
- via Jeffrey K. Tong
- via John Maraganore
- via Reid M. Huber
- via Robert J. Perez
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $47,183,170
- 73 sales by 6 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 23, 2026 | Abraham Ceesay Director, Officer (Chief Executive Officer) | Open-market sale | −1,952 | $39.05 | $76,230 |
| Sep 23, 2026 | Abraham Ceesay Director, Officer (Chief Executive Officer) | Open-market sale | −215 | $39.86 | $8,570 |
| Sep 23, 2026 | Abraham Ceesay Director, Officer (Chief Executive Officer) | Open-market sale | −43 | $41.05 | $1,765 |
| Sep 8, 2026 | Abraham Ceesay Director, Officer (Chief Executive Officer) | Open-market sale | −7,141 | $45.56 | $325,308 |
| Sep 8, 2026 | Abraham Ceesay Director, Officer (Chief Executive Officer) | Open-market sale | −1,069 | $46.01 | $49,190 |
| Aug 25, 2026 | Abraham Ceesay Director, Officer (Chief Executive Officer) | Open-market sale | −18,921 | $49.57 | $937,957 |
| Aug 25, 2026 | Yeleswaram Krishnaswamy Officer (Chief Development Officer) | Open-market sale | −20,799 | $50.31 | $1,046,421 |
| Aug 25, 2026 | Yeleswaram Krishnaswamy Officer (Chief Development Officer) | Open-market sale | −16,201 | $51.06 | $827,184 |
| Aug 24, 2026 | Yeleswaram Krishnaswamy Officer (Chief Development Officer) | Open-market sale | −13,160 | $50.00 | $657,978 |
| Aug 19, 2026 | Yeleswaram Krishnaswamy Officer (Chief Development Officer) | Open-market sale | −404 | $49.90 | $20,160 |
| Aug 11, 2026 | Abraham Ceesay Director, Officer (Chief Executive Officer) | Open-market sale | −3,664 | $46.90 | $171,837 |
| Aug 11, 2026 | Abraham Ceesay Director, Officer (Chief Executive Officer) | Open-market sale | −19,500 | $48.04 | $936,846 |
| Aug 11, 2026 | Abraham Ceesay Director, Officer (Chief Executive Officer) | Open-market sale | −5,794 | $48.62 | $281,721 |
| Aug 10, 2026 | Abraham Ceesay Director, Officer (Chief Executive Officer) | Open-market sale | −14,171 | $45.97 | $651,492 |
| Aug 10, 2026 | Abraham Ceesay Director, Officer (Chief Executive Officer) | Open-market sale | −8,370 | $46.75 | $391,280 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.